Grand Canyon Education LOPE Q1 2026 Earnings EPS Slightly Beats Estimates Shares Edge Higher AIM ImmunoTech Q1 2026 Earnings EPS Miss Widens as Clinical Pipeline Drives Higher Operating Costs Dave Inc Q1 2026 Earnings Strong EPS Beat Drives Positive Surprise Despite Stock Pullback COCH Q1 2026 Earnings Significant EPS Beat Amid Revenue Uncertainty TSAT Q1 2026 Earnings Significant EPS Miss as Revenue Details Remain Unavailable PROP Q1 2026 Earnings Significant EPS Miss but Stock Climbs 9